Study sounds alarm on sleep-aid ingredient zolpidem

Carly Helfand

Sleep aids have landed in the safety spotlight recently, with regulatory agencies lowering dosages on some meds to ease side effect worries. But overmedication has its own set of risks, and a new says those resulted in a doubling of emergency department visits between 2005 and 2010.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS